SISSA DIGITAL LIBRARYInstitutional Research Information System (Statistiche: prodotti, OA)
Per informazioni contatta [email protected]

Legname, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 28.174
NA - Nord America 24.617
AS - Asia 15.577
SA - Sud America 2.006
AF - Africa 274
Continente sconosciuto - Info sul continente non disponibili 113
OC - Oceania 39
Totale 70.800
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.649
RU - Federazione Russa 13.306
SG - Singapore 5.280
CN - Cina 4.840
IT - Italia 3.245
SE - Svezia 2.828
IE - Irlanda 2.401
BR - Brasile 1.709
UA - Ucraina 1.475
TR - Turchia 1.410
DE - Germania 1.169
VN - Vietnam 1.155
HK - Hong Kong 1.082
GB - Regno Unito 1.052
KR - Corea 772
CA - Canada 762
FR - Francia 686
FI - Finlandia 617
LU - Lussemburgo 263
IN - India 223
NL - Olanda 161
AT - Austria 159
PL - Polonia 143
MX - Messico 138
CH - Svizzera 136
BD - Bangladesh 135
JP - Giappone 128
ES - Italia 120
AR - Argentina 116
EU - Europa 108
BE - Belgio 100
ZA - Sudafrica 83
IQ - Iraq 82
GR - Grecia 65
LB - Libano 55
UZ - Uzbekistan 55
ID - Indonesia 54
PK - Pakistan 47
RO - Romania 47
VE - Venezuela 41
EC - Ecuador 40
MA - Marocco 34
CO - Colombia 33
SA - Arabia Saudita 32
CZ - Repubblica Ceca 31
LT - Lituania 28
PT - Portogallo 25
AZ - Azerbaigian 24
AU - Australia 23
EG - Egitto 23
PH - Filippine 22
TN - Tunisia 22
AE - Emirati Arabi Uniti 21
CL - Cile 21
DZ - Algeria 21
AL - Albania 18
IL - Israele 18
KE - Kenya 18
MD - Moldavia 17
JO - Giordania 16
TH - Thailandia 15
DO - Repubblica Dominicana 14
NP - Nepal 14
NZ - Nuova Zelanda 14
PE - Perù 14
PY - Paraguay 12
UY - Uruguay 12
MY - Malesia 11
BG - Bulgaria 10
ET - Etiopia 10
CR - Costa Rica 9
HU - Ungheria 9
JM - Giamaica 9
PA - Panama 9
DK - Danimarca 8
KZ - Kazakistan 8
OM - Oman 8
PS - Palestinian Territory 8
SY - Repubblica araba siriana 8
BY - Bielorussia 7
CI - Costa d'Avorio 7
SI - Slovenia 7
BO - Bolivia 6
GA - Gabon 6
HR - Croazia 6
LK - Sri Lanka 6
LV - Lettonia 6
MN - Mongolia 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
AO - Angola 5
CG - Congo 5
CY - Cipro 5
HN - Honduras 5
IR - Iran 5
NO - Norvegia 5
TW - Taiwan 5
AM - Armenia 4
KG - Kirghizistan 4
Totale 70.704
Salva come PNG Salva come JPEG
Città #
Moscow 3.604
Chandler 2.689
Singapore 2.466
Dublin 2.399
San Jose 2.276
Ashburn 1.958
Jacksonville 1.782
Scuola 1.668
Dallas 1.597
Ann Arbor 1.211
Hong Kong 1.059
New York 1.059
Wilmington 906
Boardman 872
Beijing 845
Izmir 792
Hefei 745
Saint Petersburg 729
Nanjing 632
Toronto 590
The Dalles 584
Istanbul 530
Woodbridge 513
Seoul 390
Columbus 387
Los Angeles 368
Ho Chi Minh City 346
Shanghai 339
Princeton 330
Dearborn 320
Houston 319
Lauterbourg 311
Santa Clara 303
Pisa 302
Hanoi 258
Helsinki 252
Nanchang 251
Council Bluffs 241
Ogden 236
Buffalo 206
Brooklyn 194
São Paulo 172
Milan 171
Orem 166
Luxembourg 162
Munich 149
Dong Ket 130
Kunming 125
Trieste 122
Tokyo 112
Sauris 104
Seattle 100
Warsaw 99
Brussels 98
Falls Church 97
Tianjin 96
Dudelange 90
Nuremberg 87
Vienna 85
Montreal 82
Turku 82
Shenyang 79
Chennai 76
Hebei 76
Chicago 73
Changsha 72
Denver 71
Atlanta 70
Stockholm 69
Hangzhou 67
Poplar 63
Boston 62
Rome 62
London 61
Da Nang 60
Rio de Janeiro 59
Johannesburg 58
Phoenix 58
Verona 58
Jiaxing 57
Lausanne 54
Frankfurt am Main 53
San Francisco 52
Haiphong 50
Falkenstein 48
Ankara 45
Manchester 44
Mumbai 44
Changchun 43
Washington 43
Berlin 41
Yubileyny 41
Amsterdam 40
Guangzhou 39
Belo Horizonte 38
Jakarta 38
Las Vegas 38
Orange 38
Redondo Beach 38
Frankfurt Am Main 37
Totale 41.303
Salva come PNG Salva come JPEG
Nome #
Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories 489
alpha-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication 375
Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia 371
Brain aging: A Ianus-faced player between health and neurodegeneration 368
Characterization of prion protein function by focal neurite stimulation 364
The non-octarepeat copper binding site of the prion protein is a key regulator of prion conversion 334
Differential overexpression of SERPINA3 in human prion diseases 333
Hemoglobin mRNA changes in the frontal cortex of patients with neurodegenerative diseases 324
Prion protein and copper cooperatively protect neurons by modulating NMDA receptor through S-nitrosylation 322
Synthetic mammalian prions 322
Altered Brain Hemoglobin Gene Expression in the Frontal Cortex of Patients with Alzheimer’s and Acquired Creutzfeldt-Jakob’s Disease 316
The N Terminus of the Prion Protein Mediates Functional Interactions with the Neuronal Cell Adhesion Molecule (NCAM) Fibronectin Domain 312
Whole blood gene expression profiling in preclinical and clinical cattle infected with atypical bovine spongiform encephalopathy 310
A new approach to follow a single extracellular vesicle-cell interaction using optical tweezers 309
Synthetic prions with novel strain-specified properties 302
Structural features of human prion protein variants revealed by NMR 300
Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy 296
Gene Expression Profiling of Prion-Infected Brains: a Novel Disease Signature for Neurodegeneration in Humans 295
Synthetic prions and other human neurodegenerative proteinopathies 293
Serpin inhibitors for the treatment of prion and prion-like diseases 293
Nanoparticelle di oro rivestite con polielettroliti e loro uso come medicamento per il trattamento di malattie neurodegenerative causate da aggregati proteici 288
A structural characterization of recombinant mouse prion protein amyloid fibers 285
Cellular prion protein: Role in excitotoxicity and in metal ions homeostasis 285
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer’s and Prion Diseases 284
The mechanisms of humic substances self-assembly with biological molecules: The case study of the prion protein 284
Soil humic substances hinder the propagation of prions 283
A single point mutation, a way to prion disease? 280
Anti-prion activity generated by two soil compounds-Humic and fulvic acids 280
Developmental prion protein expression in eutherian and methaterian mammalian central nervous system 275
A search for auxiliary proteins in prion replication 274
Recent Advances of Biology and Medicinal Chemistry of Prion Protein and Prions: On the Road to Therapeutics 270
Nucleotide sequences coding for ribosome inactivating proteins 269
Processo per la preparazione di proteine inibenti i ribosomi 268
Prion protein interaction with soil humic substances: environmental implications 268
NMR structure of the human prion protein with the pathological Q212P mutation: insights into inherited human prion diseases 268
Conformational properties of intrinsically disordered proteins bound to the surface of silica nanoparticles 267
Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques 266
Anti-GM1 IgM antibodies in motor neuron disease (MND) and other neurological diseases 266
Preface 266
A novel expression system for production of soluble prion proteins in E.coli 265
Anti-CD30 immunotoxins with native and recombinant dianthin 30 265
Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site 263
Identification of novel fluorescent probes preventing PrPSc replication in prion diseases 261
Nanobody-stabilize the crystal structure of full-length human PrP 261
New insights into structural determinants of prion protein folding and stability 261
Synthetic prions: De novo prion-infected neuronal cell lines and the generation of diverse infectious materials 261
Defined α-synuclein prion-like molecular assemblies spreading in cell culture 260
Whole transcriptome analysis in brains from BSE-infected macaques 260
Methionine oxidation in α-synuclein inhibits its propensity for ordered secondary structure 260
Early structural features in mammalian prion conformation conversion 259
NMR Structures of the Human Prion Protein with Pathological Mutations: Insights Into Molecular Basis of Prion Disease 259
Developmental influence of the cellular prion protein on the gene expression profile in mouse hippocampus 259
The role of the prion protein in the internalization of α-synuclein amyloids 258
NMR structure of the human prion protein Q212P mutant 257
In Absence of the Cellular Prion Protein, Alterations in Copper Metabolism and Copper-Dependent Oxidase Activity Affect Iron Distribution 256
A system-level approach for deciphering the transcriptional response to prion infection 256
Humic substances underlies the odds of environmental TSEs transmission 254
In Vitro Aggregation Assays for the Characterization of α-synuclein Prion-Like Properties 253
Antemortem Prion Diagnostics 253
Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations 253
AGFD 199 - Isolation and characterization of new anti-PrP monoclonal antibodies 252
Oriented immobilization of prion protein demonstrated via precise interfacial nanostructure measurements 250
Aberrant ERK 1/2 complex activation and localization in scrapie-infected GT1-1 cells 250
Antagonistic cellular functions for prion protein and its paralog doppel. 250
A change in the conformation of prions accompanies the emergence of a new prion strain 250
Characterization of four new monoclonal antibodies against the distal N-terminal region of PrP(c) 249
Cloning and characterization of a gene, inducible by cytokines 247
NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features 247
Structural Variations of Prion Proteins Caused by Mutations in Human Genome 246
Altered molecular signaling in neuronal cell models of prion infection 246
TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients 246
Use of different RT-QuIC substrates for detecting CWD prions in the brain of Norwegian cervids 246
Prions 245
Pin1 and neurodegeneration: a new player for prion disorders? 245
Dominant-negative effects in prion diseases: insights from molecular dynamics simulations on mouse prion protein chimeras 245
Astrocytes-derived extracellular vesicles in motion at the neuron surface: Involvement of the prion protein 244
Structural determinants in prion protein folding and stability 239
Opposite Structural Effects of Epigallocatechin-3-gallate and Dopamine Binding to α-Synuclein 239
Prion and prion-like protein strains: Deciphering the molecular basis of heterogeneity in neurodegeneration 238
Structural facets of disease-linked human prion protein mutants: A molecular dynamic study 238
Ligands binding to prion protein for use in the treatment of synucleinopathies 237
In silico/in vitro screening and hit evaluation identified new phenothiazine anti-prion derivatives 237
Aged PrP null mice show defective processing of neuregulins in the peripheral nervous system 236
Brain delivery of AVV9 expressing anti-PrP molecules delays prion disease onsite in mice 235
Prion protein and aging 234
Developmental role of the prion protein in the nervous system 234
De novo generation of mammalian prions 234
NMR Structural Studies of Human Cellular Prion Proteins 233
Insights into molecular structures of human prion proteins with inherited mutations by NMR 233
Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation 232
Humic substances and uses thereof in agro-environment 232
Effect of extracellular vesicles derived from distinct brain cells on A beta toxicity and assembly: focus on microglia derived vesicles 232
A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles 231
Humic substances and therapeutic uses thereof 231
Induction of Protease-Resistant Prion Protein and alpha-synuclein Aggregation by Human alpha-synuclein Fibrils in Cultured Cells 229
Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice 228
Inferring prion partners from Gene-Networks 228
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors 228
Method of amplifying infectious proteins 226
NMR studies of human prion protein mutants in solution 224
Totale 26.834
Salva come PNG Salva come JPEG
Categoria #
all - tutte 257.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 257.283
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.052 0 0 0 0 0 0 0 0 0 382 149 521
2021/20223.292 483 370 18 334 568 94 202 365 144 107 195 412
2022/20238.209 1.218 896 735 782 431 1.663 883 528 769 62 114 128
2023/20244.799 279 71 178 82 708 1.960 184 261 739 66 59 212
2024/202516.623 2.325 800 1.519 3.663 1.677 719 799 843 660 544 1.502 1.572
2025/202622.363 986 1.971 1.668 2.404 3.453 5.121 3.966 951 1.107 736 0 0
Totale 72.141